Five-Year Survival Outcomes of Hybrid Minimally Invasive Esophagectomy in Esophageal Cancer: Results of the MIRO Randomized Clinical Trial.

MLA

Nuytens, Frederiek, et al. “Five-Year Survival Outcomes of Hybrid Minimally Invasive Esophagectomy in Esophageal Cancer: Results of the MIRO Randomized Clinical Trial.” JAMA Surgery, vol. 156, no. 4, Apr. 2021, pp. 323–32. EBSCOhost, https://doi.org/10.1001/jamasurg.2020.7081.

APA

Nuytens, F., Dabakuyo-Yonli, T. S., Meunier, B., Gagnière, J., Collet, D., D’Journo, X. B., Brigand, C., Perniceni, T., Carrère, N., Mabrut, J.-Y., Msika, S., Peschaud, F., Prudhomme, M., Markar, S. R., & Piessen, G. (2021). Five-Year Survival Outcomes of Hybrid Minimally Invasive Esophagectomy in Esophageal Cancer: Results of the MIRO Randomized Clinical Trial. JAMA Surgery, 156(4), 323–332. https://doi.org/10.1001/jamasurg.2020.7081

Chicago

Nuytens, Frederiek, Tienhan Sandrine Dabakuyo-Yonli, Bernard Meunier, Johan Gagnière, Denis Collet, Xavier B D’Journo, Cécile Brigand, et al. 2021. “Five-Year Survival Outcomes of Hybrid Minimally Invasive Esophagectomy in Esophageal Cancer: Results of the MIRO Randomized Clinical Trial.” JAMA Surgery 156 (4): 323–32. doi:10.1001/jamasurg.2020.7081.